Treatment of pediatric refractory Crohn&rsquo;s disease with thalidomide

doi:10.3748/wjg.v17.i10.1286

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 10

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5064)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

348

HTML

4304

Figures (1-2)

219

Tables (1-1)

193

Sum=5064

Mar 14, 2011 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Mar 14, 2011; 17(10): 1286-1291
Published online Mar 14, 2011. doi: 10.3748/wjg.v17.i10.1286

Open in New Tab Full Size Figure Download Figure

Figure 1 Mean pediatric Crohn’s disease activity index during thalidomide treatment. ^aP < 0.0005. PCDAI: Pediatric Crohnâs disease activity index.

Open in New Tab Full Size Figure Download Figure

Figure 2 Endoscopy views of patients A, B, C, F before thalidomide treatment (A-D) and six months after thalidomide treatment (E-H).

Citation: Zheng CF, Xu JH, Huang Y, Leung YK. Treatment of pediatric refractory Crohn’s disease with thalidomide. World J Gastroenterol 2011; 17(10): 1286-1291
URL: https://www.wjgnet.com/1007-9327/full/v17/i10/1286.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i10.1286